Javier Escaned: 3 Low contrast complex and CTO PCI
1. Ultra-low contrast in complex and CTO
PCI cases
Javier Escaned MD PhD
Hospital Clinico San Carlos
Madrid / Spain
2. EuroPCR.com
Potential conflicts of interest
Speaker's name : Javier Escaned
I have the following potential conflict of interest to declare:
Advisory board member: Abbott, Philips
Speaker at educational events: Abbott, Abiomed, Boston Scientific,
Medis, Philips
4. EuroPCR.com
• Selecting PCI candidates
• Identifying flow-limiting lesions
• Planning the intervention
• Choosing devices
• Deciding when an adequate PCI result
has been achieved
• Establishing the cause of PCI failure
The central role of angiography in the PCI culture
5. EuroPCR.com
• Selecting PCI candidates
• Identifying flow-limiting lesions
• Planning the intervention
• Choosing devices
• Deciding when an adequate PCI result
has been achieved
• Establishing the cause of PCI failure
45 years later we have more and better tools than angiography
CTCA IVUS
iFR / FFR DCR
6. EuroPCR.com
An example of the value of ULC: renal patients undergoing PCI
AKI leading to loss of
residual renal function
Suboptimal quality of
revascularisation → residual
ischemia / stent failure
Bleeding and ischaemic
events linked to PCI
7. EuroPCR.com
Benefit in CKD patients: beyond avoidance of acute kidney injury
High
High
Low
CKD
Ca2+ managed with
plaque preparation and
IVUS guidance → better
long-term outcomes
Contrast-induced
nephropathy is
avoided
Improved PCI results
decrease dependence on
antiplatelet treatment
8. EuroPCR.com
• Very severe LV dysfunction
• Very severe contrast allergy
• Severe thyroid dysfunction
• Anticipated long procedures (MVD, CTO)
• Iatrogenic coronary dissections
• Spontaneous coronary dissection
• CTO treated with CART / ADR
Clinical contexts in which ULC PCI is useful
• Chronic kidney disease
• Prior AKI
• Renal transplant
• Concomitant contrast-based tests (CTCA)
• Shock / Out-of-hospital cardiac arrest
• Emergency PCI with unknown eGFR
• Patient frailty
10. • How can I know where the artery is? (ostium)
• How could I possibly navigate wires without
seeing the vessel?
• Where is the lesion I have to treat?
• How do I know I am treating / stenting the right
site?
• How do I know I have obtained a good result?
• How can I rule that there are complications?
• What is the final result of the intervention?
Challenges of performing PCI without vessel opacification
???
???
16. 3.5 - 4.0 mm
Wire-based IVUS and physiology coregistration
- Planning-
17. 2.6 - 3.0 mm
3.5 - 4.0 mm
Wire-based IVUS and physiology coregistration
- Guidance -
18. Lesion coverage, stent expansión/apposition, dissections Functional result
Wire-based IVUS and physiology coregistration
- Evaluation of results and optimisation -
19. EuroPCR.com
Ultralow contrast skills/tools as part of state-of-the-art PCI
Setting the indication and
predicting PCI effectiveness
Performing high-quality
revascularisation
ULCPCI
20. EuroPCR.com
Dedicated chapter on ULC PCI in the PCR-EAPCI Textbook
Use of ultra-low contrast techniques in
percutaneous coronary interventions
Alejandro Travieso MD, Breda Hennessey MD, Asad Shabbir MD,
Adrian Jerónimo, Nieves Gonzalo MD PhD, Javier Escaned MD PhD
21. Thank you for your attention
OPTIMAL CTO 2019
London, June 5-6 2019